Results 181 to 190 of about 89,290 (238)

Aminoglycosides enhance meropenem/vaborbactam activity against KPC-producing <i>Klebsiella pneumoniae</i> in the hollow fiber infection model. [PDF]

Antimicrob Agents Chemother
Singh N, Jogan CML, Zang Y, Shan X, Lang Y, Karunanidhi A, Watkins JV, Curry BN, Tamma PD, Nozick SH, Ozer EA, Hauser AR, Bulitta JB, Bulman ZP.   +13 more
europepmc   +1 more source

<i>In vitro</i> activity of the novel β-lactamase inhibitor nacubactam against a nationwide collection of carbapenem-resistant Enterobacterales in Japan. [PDF]

JAC Antimicrob Resist
Yanagihara K, Tateda K, Doi Y, Takahashi S, Ohge H, Itahashi K, Okade H, Mikamo H.   +7 more
europepmc   +1 more source

The emergence of NDM-1, IMP-7, IMP-26, IMP-62, IMP-76, VIM-4 and VIM-5 producing Pseudomonas aeruginosa strains, identification of a novel sequence type (ST3891) and analysis of virulence genes from a Malaysian tertiary hospital. [PDF]

PLoS One
Kalai Chelvam K, Lim YM, Teh CSJ, Ponnampalavanar S, Vadivelu J, Mariappan V, Vellasamy KM.   +6 more
europepmc   +1 more source

<i>In vitro</i> activity of aztreonam-nacubactam and cefepime-nacubactam against a global collection of clinically important Gram-negative Bacilli collected in 2021-2023. [PDF]

JAC Antimicrob Resist
Karlowsky JA, Estabrook M, Suzuki E, Shimizu A, Okade H.   +4 more
europepmc   +1 more source

Simultaneous electrochemical detection of imipenem and meropenem using a Pt-Au bimetallic nanoparticle-decorated 3D graphene oxide modified glassy carbon electrode. [PDF]

Sci Rep
Paghaleh HJ, Jahani S, Moradalizadeh M, Foroughi MM.   +3 more
europepmc   +1 more source

A case of splenic abscess complicated with intra-abdominal free gas misdiagnosed as gastrointestinal perforation. [PDF]

J Surg Case Rep
Du W.
europepmc   +1 more source

Pharmacokinetic-pharmacodynamic modeling to evaluate the relative impact of immune response and meropenem on bacterial killing <i>in vivo</i>. [PDF]

Antimicrob Agents Chemother
Saporta R, Tassi N, Biordi V, Ticha O, Ginosyan A, Loryan I, Nielsen EI, Bekeredjian-Ding I, Kerscher B, Friberg LE.   +9 more
europepmc   +1 more source

Bayesian Dosing Simulator (BDS): A Pharmacokinetic Modeling Tool for Optimized Antibiotic Therapy. [PDF]

Pharmacotherapy
Valadez A, Scheetz MH, Neely MN, Donnelly HK, Korth E, Wunderink RG, Rhodes NJ.   +6 more
europepmc   +1 more source

Achieving target plasma concentrations of beta-lactam antibiotics in critically ill patients: a retrospective study of full-dose administration in the first 24 hours. [PDF]

Pharmacol Rep
Halačová M, Mieresová M, Kubele J, Klapková E, Černý D, Waldauf P, Duška F.   +6 more
europepmc   +1 more source